nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—CYP2A6—Methoxsalen—psoriasis	0.11	0.181	CbGbCtD
Sevoflurane—ALB—Acitretin—psoriasis	0.0863	0.142	CbGbCtD
Sevoflurane—CYP2A6—Prednisolone—psoriasis	0.0536	0.0882	CbGbCtD
Sevoflurane—CYP2B6—Cholecalciferol—psoriasis	0.0475	0.0782	CbGbCtD
Sevoflurane—ALB—Mycophenolate mofetil—psoriasis	0.0404	0.0665	CbGbCtD
Sevoflurane—ALB—Prednisone—psoriasis	0.0323	0.0531	CbGbCtD
Sevoflurane—CYP2A6—Dexamethasone—psoriasis	0.0316	0.052	CbGbCtD
Sevoflurane—CYP3A4—Calcitriol—psoriasis	0.0283	0.0466	CbGbCtD
Sevoflurane—CYP3A4—Methoxsalen—psoriasis	0.022	0.0363	CbGbCtD
Sevoflurane—CYP2E1—Dexamethasone—psoriasis	0.0209	0.0343	CbGbCtD
Sevoflurane—CYP2B6—Dexamethasone—psoriasis	0.0206	0.0339	CbGbCtD
Sevoflurane—ALB—Methotrexate—psoriasis	0.0162	0.0267	CbGbCtD
Sevoflurane—CYP3A4—Cholecalciferol—psoriasis	0.0146	0.024	CbGbCtD
Sevoflurane—CYP3A4—Mycophenolate mofetil—psoriasis	0.0127	0.0208	CbGbCtD
Sevoflurane—CYP3A4—Triamcinolone—psoriasis	0.0127	0.0208	CbGbCtD
Sevoflurane—CYP3A4—Betamethasone—psoriasis	0.0109	0.0179	CbGbCtD
Sevoflurane—CYP3A4—Prednisolone—psoriasis	0.0107	0.0176	CbGbCtD
Sevoflurane—CYP3A4—Hydrocortisone—psoriasis	0.0102	0.0167	CbGbCtD
Sevoflurane—CYP3A4—Prednisone—psoriasis	0.0101	0.0167	CbGbCtD
Sevoflurane—CYP3A4—Cyclosporine—psoriasis	0.0096	0.0158	CbGbCtD
Sevoflurane—CYP3A4—Dexamethasone—psoriasis	0.00632	0.0104	CbGbCtD
Sevoflurane—ND1—Oxidative phosphorylation—NDUFA5—psoriasis	0.00237	0.0537	CbGpPWpGaD
Sevoflurane—ATP5D—Oxidative phosphorylation—NDUFA5—psoriasis	0.00237	0.0537	CbGpPWpGaD
Sevoflurane—CYP2A6—CYP2E1 reactions—CYP2S1—psoriasis	0.0021	0.0476	CbGpPWpGaD
Sevoflurane—ND1—Respiratory electron transport—NDUFA5—psoriasis	0.00177	0.0402	CbGpPWpGaD
Sevoflurane—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.00169	0.0384	CbGpPWpGaD
Sevoflurane—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.00166	0.0376	CbGpPWpGaD
Sevoflurane—ATP5D—Electron Transport Chain—NDUFA5—psoriasis	0.00154	0.0348	CbGpPWpGaD
Sevoflurane—ND1—Electron Transport Chain—NDUFA5—psoriasis	0.00154	0.0348	CbGpPWpGaD
Sevoflurane—ATP5D—Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.—NDUFA5—psoriasis	0.0015	0.034	CbGpPWpGaD
Sevoflurane—ND1—Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.—NDUFA5—psoriasis	0.0015	0.034	CbGpPWpGaD
Sevoflurane—CYP2A6—Xenobiotics—CYP2S1—psoriasis	0.0013	0.0295	CbGpPWpGaD
Sevoflurane—ND1—The citric acid (TCA) cycle and respiratory electron transport—NDUFA5—psoriasis	0.00116	0.0262	CbGpPWpGaD
Sevoflurane—ATP5D—The citric acid (TCA) cycle and respiratory electron transport—NDUFA5—psoriasis	0.00116	0.0262	CbGpPWpGaD
Sevoflurane—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.00105	0.0238	CbGpPWpGaD
Sevoflurane—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00103	0.0233	CbGpPWpGaD
Sevoflurane—GRIA1—Amyotrophic lateral sclerosis (ALS)—CAT—psoriasis	0.00066	0.015	CbGpPWpGaD
Sevoflurane—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00054	0.0122	CbGpPWpGaD
Sevoflurane—CYP2A6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000533	0.0121	CbGpPWpGaD
Sevoflurane—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000477	0.0108	CbGpPWpGaD
Sevoflurane—CYP2A6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000438	0.00992	CbGpPWpGaD
Sevoflurane—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000436	0.00987	CbGpPWpGaD
Sevoflurane—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00043	0.00975	CbGpPWpGaD
Sevoflurane—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000427	0.00967	CbGpPWpGaD
Sevoflurane—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000421	0.00954	CbGpPWpGaD
Sevoflurane—GABRQ—Orphan transporters—CARM1—psoriasis	0.000364	0.00824	CbGpPWpGaD
Sevoflurane—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000353	0.00801	CbGpPWpGaD
Sevoflurane—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000346	0.00784	CbGpPWpGaD
Sevoflurane—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.000338	0.00766	CbGpPWpGaD
Sevoflurane—GABRG3—Orphan transporters—CARM1—psoriasis	0.000299	0.00679	CbGpPWpGaD
Sevoflurane—GABRB1—Orphan transporters—CARM1—psoriasis	0.000295	0.00669	CbGpPWpGaD
Sevoflurane—GABRA6—Orphan transporters—CARM1—psoriasis	0.000279	0.00633	CbGpPWpGaD
Sevoflurane—GABRA4—Orphan transporters—CARM1—psoriasis	0.000276	0.00625	CbGpPWpGaD
Sevoflurane—ALB—HDL-mediated lipid transport—APOE—psoriasis	0.000259	0.00588	CbGpPWpGaD
Sevoflurane—Hypertension—Prednisolone—psoriasis	0.000255	0.000732	CcSEcCtD
Sevoflurane—Shock—Mycophenolate mofetil—psoriasis	0.000254	0.000729	CcSEcCtD
Sevoflurane—Loss of consciousness—Hydrocortisone—psoriasis	0.000253	0.000727	CcSEcCtD
Sevoflurane—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000253	0.000727	CcSEcCtD
Sevoflurane—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000253	0.000726	CcSEcCtD
Sevoflurane—Arrhythmia—Dexamethasone—psoriasis	0.000253	0.000726	CcSEcCtD
Sevoflurane—Arrhythmia—Betamethasone—psoriasis	0.000253	0.000726	CcSEcCtD
Sevoflurane—Pancreatitis—Methotrexate—psoriasis	0.000252	0.000724	CcSEcCtD
Sevoflurane—GABRB2—Orphan transporters—CARM1—psoriasis	0.000252	0.00571	CbGpPWpGaD
Sevoflurane—Tachycardia—Mycophenolate mofetil—psoriasis	0.000252	0.000724	CcSEcCtD
Sevoflurane—Skin disorder—Mycophenolate mofetil—psoriasis	0.000251	0.00072	CcSEcCtD
Sevoflurane—Bradycardia—Prednisone—psoriasis	0.000251	0.00072	CcSEcCtD
Sevoflurane—Convulsion—Hydrocortisone—psoriasis	0.00025	0.000717	CcSEcCtD
Sevoflurane—Hypertension—Hydrocortisone—psoriasis	0.000249	0.000715	CcSEcCtD
Sevoflurane—Vomiting—Hydroxyurea—psoriasis	0.000248	0.000713	CcSEcCtD
Sevoflurane—Haemoglobin—Prednisone—psoriasis	0.000248	0.000711	CcSEcCtD
Sevoflurane—Haemorrhage—Prednisone—psoriasis	0.000246	0.000707	CcSEcCtD
Sevoflurane—Rash—Hydroxyurea—psoriasis	0.000246	0.000707	CcSEcCtD
Sevoflurane—Dermatitis—Hydroxyurea—psoriasis	0.000246	0.000707	CcSEcCtD
Sevoflurane—GABRA5—Orphan transporters—CARM1—psoriasis	0.000245	0.00555	CbGpPWpGaD
Sevoflurane—Headache—Hydroxyurea—psoriasis	0.000245	0.000703	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000244	0.0007	CcSEcCtD
Sevoflurane—Syncope—Triamcinolone—psoriasis	0.000243	0.000699	CcSEcCtD
Sevoflurane—Hypotension—Mycophenolate mofetil—psoriasis	0.000241	0.000693	CcSEcCtD
Sevoflurane—Oedema—Prednisolone—psoriasis	0.000241	0.000692	CcSEcCtD
Sevoflurane—Anaphylactic shock—Prednisolone—psoriasis	0.000241	0.000692	CcSEcCtD
Sevoflurane—Dysuria—Methotrexate—psoriasis	0.00024	0.000691	CcSEcCtD
Sevoflurane—GABRA3—Orphan transporters—CARM1—psoriasis	0.00024	0.00545	CbGpPWpGaD
Sevoflurane—Insomnia—Cyclosporine—psoriasis	0.000239	0.000687	CcSEcCtD
Sevoflurane—Loss of consciousness—Triamcinolone—psoriasis	0.000238	0.000685	CcSEcCtD
Sevoflurane—GRIA1—Amyotrophic lateral sclerosis (ALS)—TNF—psoriasis	0.000237	0.00538	CbGpPWpGaD
Sevoflurane—Shock—Prednisolone—psoriasis	0.000237	0.00068	CcSEcCtD
Sevoflurane—Cough—Triamcinolone—psoriasis	0.000237	0.00068	CcSEcCtD
Sevoflurane—GABRA2—Orphan transporters—CARM1—psoriasis	0.000236	0.00536	CbGpPWpGaD
Sevoflurane—Dyspnoea—Cyclosporine—psoriasis	0.000236	0.000678	CcSEcCtD
Sevoflurane—Somnolence—Cyclosporine—psoriasis	0.000235	0.000676	CcSEcCtD
Sevoflurane—Anaphylactic shock—Hydrocortisone—psoriasis	0.000235	0.000676	CcSEcCtD
Sevoflurane—Oedema—Hydrocortisone—psoriasis	0.000235	0.000676	CcSEcCtD
Sevoflurane—Convulsion—Triamcinolone—psoriasis	0.000235	0.000675	CcSEcCtD
Sevoflurane—Tachycardia—Prednisolone—psoriasis	0.000235	0.000675	CcSEcCtD
Sevoflurane—GABRB3—Orphan transporters—CARM1—psoriasis	0.000235	0.00532	CbGpPWpGaD
Sevoflurane—Asthenia—Mycophenolic acid—psoriasis	0.000235	0.000674	CcSEcCtD
Sevoflurane—Hypertension—Triamcinolone—psoriasis	0.000234	0.000673	CcSEcCtD
Sevoflurane—Insomnia—Mycophenolate mofetil—psoriasis	0.000233	0.000671	CcSEcCtD
Sevoflurane—CYP2A6—Biological oxidations—CYP2S1—psoriasis	0.000233	0.00527	CbGpPWpGaD
Sevoflurane—Nausea—Hydroxyurea—psoriasis	0.000232	0.000666	CcSEcCtD
Sevoflurane—Pruritus—Mycophenolic acid—psoriasis	0.000231	0.000665	CcSEcCtD
Sevoflurane—Shock—Hydrocortisone—psoriasis	0.000231	0.000665	CcSEcCtD
Sevoflurane—Nervous system disorder—Hydrocortisone—psoriasis	0.000231	0.000662	CcSEcCtD
Sevoflurane—GABRG2—Orphan transporters—CARM1—psoriasis	0.000231	0.00523	CbGpPWpGaD
Sevoflurane—Dyspnoea—Mycophenolate mofetil—psoriasis	0.00023	0.000661	CcSEcCtD
Sevoflurane—Tachycardia—Hydrocortisone—psoriasis	0.00023	0.000659	CcSEcCtD
Sevoflurane—Somnolence—Mycophenolate mofetil—psoriasis	0.000229	0.000659	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000228	0.000656	CcSEcCtD
Sevoflurane—Skin disorder—Hydrocortisone—psoriasis	0.000228	0.000656	CcSEcCtD
Sevoflurane—Pain—Cyclosporine—psoriasis	0.000226	0.00065	CcSEcCtD
Sevoflurane—Dry mouth—Triamcinolone—psoriasis	0.000226	0.000649	CcSEcCtD
Sevoflurane—Renal failure—Methotrexate—psoriasis	0.000225	0.000647	CcSEcCtD
Sevoflurane—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.000224	0.00508	CbGpPWpGaD
Sevoflurane—Angiopathy—Prednisone—psoriasis	0.000223	0.000642	CcSEcCtD
Sevoflurane—Conjunctivitis—Methotrexate—psoriasis	0.000223	0.00064	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000223	0.00064	CcSEcCtD
Sevoflurane—Immune system disorder—Prednisone—psoriasis	0.000222	0.000639	CcSEcCtD
Sevoflurane—Anaphylactic shock—Triamcinolone—psoriasis	0.000221	0.000636	CcSEcCtD
Sevoflurane—Oedema—Triamcinolone—psoriasis	0.000221	0.000636	CcSEcCtD
Sevoflurane—Syncope—Dexamethasone—psoriasis	0.000221	0.000634	CcSEcCtD
Sevoflurane—Syncope—Betamethasone—psoriasis	0.000221	0.000634	CcSEcCtD
Sevoflurane—Pain—Mycophenolate mofetil—psoriasis	0.000221	0.000634	CcSEcCtD
Sevoflurane—Arrhythmia—Prednisone—psoriasis	0.00022	0.000632	CcSEcCtD
Sevoflurane—Hypotension—Hydrocortisone—psoriasis	0.00022	0.000631	CcSEcCtD
Sevoflurane—Feeling abnormal—Cyclosporine—psoriasis	0.000218	0.000626	CcSEcCtD
Sevoflurane—Shock—Triamcinolone—psoriasis	0.000218	0.000626	CcSEcCtD
Sevoflurane—Insomnia—Prednisolone—psoriasis	0.000218	0.000626	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Methotrexate—psoriasis	0.000217	0.000623	CcSEcCtD
Sevoflurane—Loss of consciousness—Dexamethasone—psoriasis	0.000216	0.000622	CcSEcCtD
Sevoflurane—Loss of consciousness—Betamethasone—psoriasis	0.000216	0.000622	CcSEcCtD
Sevoflurane—Dizziness—Mycophenolic acid—psoriasis	0.000216	0.000621	CcSEcCtD
Sevoflurane—Tachycardia—Triamcinolone—psoriasis	0.000216	0.000621	CcSEcCtD
Sevoflurane—Mental disorder—Prednisone—psoriasis	0.000216	0.00062	CcSEcCtD
Sevoflurane—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000216	0.00489	CbGpPWpGaD
Sevoflurane—Malnutrition—Prednisone—psoriasis	0.000214	0.000616	CcSEcCtD
Sevoflurane—ATP2C1—Transmembrane transport of small molecules—CP—psoriasis	0.000214	0.00485	CbGpPWpGaD
Sevoflurane—Convulsion—Betamethasone—psoriasis	0.000213	0.000613	CcSEcCtD
Sevoflurane—Convulsion—Dexamethasone—psoriasis	0.000213	0.000613	CcSEcCtD
Sevoflurane—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000213	0.000611	CcSEcCtD
Sevoflurane—Insomnia—Hydrocortisone—psoriasis	0.000213	0.000611	CcSEcCtD
Sevoflurane—Hypertension—Dexamethasone—psoriasis	0.000213	0.000611	CcSEcCtD
Sevoflurane—Hypertension—Betamethasone—psoriasis	0.000213	0.000611	CcSEcCtD
Sevoflurane—Urticaria—Cyclosporine—psoriasis	0.00021	0.000604	CcSEcCtD
Sevoflurane—GRIA1—Amyotrophic lateral sclerosis (ALS)—TP53—psoriasis	0.000209	0.00474	CbGpPWpGaD
Sevoflurane—Body temperature increased—Cyclosporine—psoriasis	0.000209	0.000601	CcSEcCtD
Sevoflurane—Vomiting—Mycophenolic acid—psoriasis	0.000208	0.000597	CcSEcCtD
Sevoflurane—Haemoglobin—Methotrexate—psoriasis	0.000207	0.000594	CcSEcCtD
Sevoflurane—Rash—Mycophenolic acid—psoriasis	0.000206	0.000592	CcSEcCtD
Sevoflurane—Dermatitis—Mycophenolic acid—psoriasis	0.000206	0.000592	CcSEcCtD
Sevoflurane—Pain—Prednisolone—psoriasis	0.000206	0.000591	CcSEcCtD
Sevoflurane—Haemorrhage—Methotrexate—psoriasis	0.000206	0.000591	CcSEcCtD
Sevoflurane—Hepatitis—Methotrexate—psoriasis	0.000206	0.000591	CcSEcCtD
Sevoflurane—Urticaria—Mycophenolate mofetil—psoriasis	0.000205	0.000589	CcSEcCtD
Sevoflurane—Headache—Mycophenolic acid—psoriasis	0.000205	0.000589	CcSEcCtD
Sevoflurane—Pharyngitis—Methotrexate—psoriasis	0.000204	0.000587	CcSEcCtD
Sevoflurane—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000204	0.000586	CcSEcCtD
Sevoflurane—ATP2C1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000204	0.00462	CbGpPWpGaD
Sevoflurane—Urinary tract disorder—Methotrexate—psoriasis	0.000203	0.000584	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000203	0.000583	CcSEcCtD
Sevoflurane—Urethral disorder—Methotrexate—psoriasis	0.000202	0.00058	CcSEcCtD
Sevoflurane—GABRA1—Orphan transporters—CARM1—psoriasis	0.000201	0.00457	CbGpPWpGaD
Sevoflurane—Pain—Hydrocortisone—psoriasis	0.000201	0.000578	CcSEcCtD
Sevoflurane—Anaphylactic shock—Betamethasone—psoriasis	0.000201	0.000577	CcSEcCtD
Sevoflurane—Oedema—Betamethasone—psoriasis	0.000201	0.000577	CcSEcCtD
Sevoflurane—Oedema—Dexamethasone—psoriasis	0.000201	0.000577	CcSEcCtD
Sevoflurane—Anaphylactic shock—Dexamethasone—psoriasis	0.000201	0.000577	CcSEcCtD
Sevoflurane—Insomnia—Triamcinolone—psoriasis	0.0002	0.000575	CcSEcCtD
Sevoflurane—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.0002	0.00454	CbGpPWpGaD
Sevoflurane—Feeling abnormal—Prednisolone—psoriasis	0.000198	0.00057	CcSEcCtD
Sevoflurane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000198	0.00449	CbGpPWpGaD
Sevoflurane—Shock—Dexamethasone—psoriasis	0.000198	0.000568	CcSEcCtD
Sevoflurane—Shock—Betamethasone—psoriasis	0.000198	0.000568	CcSEcCtD
Sevoflurane—Dyspnoea—Triamcinolone—psoriasis	0.000197	0.000567	CcSEcCtD
Sevoflurane—Nervous system disorder—Dexamethasone—psoriasis	0.000197	0.000566	CcSEcCtD
Sevoflurane—Nervous system disorder—Betamethasone—psoriasis	0.000197	0.000566	CcSEcCtD
Sevoflurane—Agitation—Prednisone—psoriasis	0.000197	0.000566	CcSEcCtD
Sevoflurane—Thrombocytopenia—Betamethasone—psoriasis	0.000197	0.000565	CcSEcCtD
Sevoflurane—Thrombocytopenia—Dexamethasone—psoriasis	0.000197	0.000565	CcSEcCtD
Sevoflurane—Tachycardia—Dexamethasone—psoriasis	0.000196	0.000563	CcSEcCtD
Sevoflurane—Tachycardia—Betamethasone—psoriasis	0.000196	0.000563	CcSEcCtD
Sevoflurane—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000196	0.00444	CbGpPWpGaD
Sevoflurane—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.000196	0.00444	CbGpPWpGaD
Sevoflurane—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000195	0.00443	CbGpPWpGaD
Sevoflurane—Hypersensitivity—Cyclosporine—psoriasis	0.000195	0.00056	CcSEcCtD
Sevoflurane—Nausea—Mycophenolic acid—psoriasis	0.000194	0.000558	CcSEcCtD
Sevoflurane—Feeling abnormal—Hydrocortisone—psoriasis	0.000194	0.000557	CcSEcCtD
Sevoflurane—Syncope—Prednisone—psoriasis	0.000192	0.000552	CcSEcCtD
Sevoflurane—Urticaria—Prednisolone—psoriasis	0.000191	0.000549	CcSEcCtD
Sevoflurane—Cardiac disorder—Methotrexate—psoriasis	0.000191	0.000549	CcSEcCtD
Sevoflurane—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.00019	0.000546	CcSEcCtD
Sevoflurane—Asthenia—Cyclosporine—psoriasis	0.00019	0.000545	CcSEcCtD
Sevoflurane—Pain—Triamcinolone—psoriasis	0.000189	0.000544	CcSEcCtD
Sevoflurane—Loss of consciousness—Prednisone—psoriasis	0.000188	0.000541	CcSEcCtD
Sevoflurane—Hypotension—Dexamethasone—psoriasis	0.000188	0.000539	CcSEcCtD
Sevoflurane—Hypotension—Betamethasone—psoriasis	0.000188	0.000539	CcSEcCtD
Sevoflurane—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000188	0.00425	CbGpPWpGaD
Sevoflurane—Pruritus—Cyclosporine—psoriasis	0.000187	0.000538	CcSEcCtD
Sevoflurane—Urticaria—Hydrocortisone—psoriasis	0.000187	0.000537	CcSEcCtD
Sevoflurane—Angiopathy—Methotrexate—psoriasis	0.000187	0.000536	CcSEcCtD
Sevoflurane—Immune system disorder—Methotrexate—psoriasis	0.000186	0.000534	CcSEcCtD
Sevoflurane—Body temperature increased—Hydrocortisone—psoriasis	0.000186	0.000534	CcSEcCtD
Sevoflurane—Convulsion—Prednisone—psoriasis	0.000186	0.000534	CcSEcCtD
Sevoflurane—Mediastinal disorder—Methotrexate—psoriasis	0.000186	0.000533	CcSEcCtD
Sevoflurane—Asthenia—Mycophenolate mofetil—psoriasis	0.000185	0.000532	CcSEcCtD
Sevoflurane—Hypertension—Prednisone—psoriasis	0.000185	0.000532	CcSEcCtD
Sevoflurane—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000185	0.00419	CbGpPWpGaD
Sevoflurane—Chills—Methotrexate—psoriasis	0.000185	0.00053	CcSEcCtD
Sevoflurane—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000184	0.00417	CbGpPWpGaD
Sevoflurane—Pruritus—Mycophenolate mofetil—psoriasis	0.000183	0.000525	CcSEcCtD
Sevoflurane—Feeling abnormal—Triamcinolone—psoriasis	0.000182	0.000524	CcSEcCtD
Sevoflurane—GLRA1—Transmembrane transport of small molecules—CP—psoriasis	0.000182	0.00412	CbGpPWpGaD
Sevoflurane—Insomnia—Betamethasone—psoriasis	0.000182	0.000522	CcSEcCtD
Sevoflurane—Insomnia—Dexamethasone—psoriasis	0.000182	0.000522	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000181	0.000521	CcSEcCtD
Sevoflurane—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000181	0.00411	CbGpPWpGaD
Sevoflurane—Mental disorder—Methotrexate—psoriasis	0.00018	0.000518	CcSEcCtD
Sevoflurane—Malnutrition—Methotrexate—psoriasis	0.000179	0.000515	CcSEcCtD
Sevoflurane—Hypersensitivity—Prednisolone—psoriasis	0.000177	0.00051	CcSEcCtD
Sevoflurane—Urticaria—Triamcinolone—psoriasis	0.000176	0.000505	CcSEcCtD
Sevoflurane—Dysgeusia—Methotrexate—psoriasis	0.000175	0.000504	CcSEcCtD
Sevoflurane—Body temperature increased—Triamcinolone—psoriasis	0.000175	0.000503	CcSEcCtD
Sevoflurane—Dizziness—Cyclosporine—psoriasis	0.000175	0.000503	CcSEcCtD
Sevoflurane—Oedema—Prednisone—psoriasis	0.000175	0.000503	CcSEcCtD
Sevoflurane—Anaphylactic shock—Prednisone—psoriasis	0.000175	0.000503	CcSEcCtD
Sevoflurane—ND1—Metabolism—NDUFA5—psoriasis	0.000174	0.00395	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—NDUFA5—psoriasis	0.000174	0.00395	CbGpPWpGaD
Sevoflurane—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000173	0.000498	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Betamethasone—psoriasis	0.000173	0.000498	CcSEcCtD
Sevoflurane—GLRA1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000173	0.00393	CbGpPWpGaD
Sevoflurane—Hypersensitivity—Hydrocortisone—psoriasis	0.000173	0.000498	CcSEcCtD
Sevoflurane—Shock—Prednisone—psoriasis	0.000172	0.000494	CcSEcCtD
Sevoflurane—Pain—Betamethasone—psoriasis	0.000172	0.000494	CcSEcCtD
Sevoflurane—Pain—Dexamethasone—psoriasis	0.000172	0.000494	CcSEcCtD
Sevoflurane—Nervous system disorder—Prednisone—psoriasis	0.000172	0.000493	CcSEcCtD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000171	0.00388	CbGpPWpGaD
Sevoflurane—Tachycardia—Prednisone—psoriasis	0.000171	0.000491	CcSEcCtD
Sevoflurane—Dizziness—Mycophenolate mofetil—psoriasis	0.000171	0.00049	CcSEcCtD
Sevoflurane—Skin disorder—Prednisone—psoriasis	0.00017	0.000488	CcSEcCtD
Sevoflurane—Asthenia—Hydrocortisone—psoriasis	0.000169	0.000485	CcSEcCtD
Sevoflurane—Vomiting—Cyclosporine—psoriasis	0.000168	0.000483	CcSEcCtD
Sevoflurane—Rash—Cyclosporine—psoriasis	0.000167	0.000479	CcSEcCtD
Sevoflurane—Dermatitis—Cyclosporine—psoriasis	0.000167	0.000479	CcSEcCtD
Sevoflurane—Pruritus—Hydrocortisone—psoriasis	0.000166	0.000478	CcSEcCtD
Sevoflurane—Headache—Cyclosporine—psoriasis	0.000166	0.000476	CcSEcCtD
Sevoflurane—Feeling abnormal—Dexamethasone—psoriasis	0.000166	0.000476	CcSEcCtD
Sevoflurane—Feeling abnormal—Betamethasone—psoriasis	0.000166	0.000476	CcSEcCtD
Sevoflurane—GRIA1—BDNF signaling pathway—NFKBIA—psoriasis	0.000165	0.00373	CbGpPWpGaD
Sevoflurane—Vomiting—Mycophenolate mofetil—psoriasis	0.000164	0.000471	CcSEcCtD
Sevoflurane—Hypersensitivity—Triamcinolone—psoriasis	0.000163	0.000469	CcSEcCtD
Sevoflurane—Rash—Mycophenolate mofetil—psoriasis	0.000163	0.000468	CcSEcCtD
Sevoflurane—Dermatitis—Mycophenolate mofetil—psoriasis	0.000163	0.000467	CcSEcCtD
Sevoflurane—Headache—Mycophenolate mofetil—psoriasis	0.000162	0.000465	CcSEcCtD
Sevoflurane—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00016	0.00364	CbGpPWpGaD
Sevoflurane—Urticaria—Dexamethasone—psoriasis	0.00016	0.000458	CcSEcCtD
Sevoflurane—Urticaria—Betamethasone—psoriasis	0.00016	0.000458	CcSEcCtD
Sevoflurane—Dizziness—Prednisolone—psoriasis	0.000159	0.000457	CcSEcCtD
Sevoflurane—Asthenia—Triamcinolone—psoriasis	0.000159	0.000456	CcSEcCtD
Sevoflurane—Body temperature increased—Betamethasone—psoriasis	0.000159	0.000456	CcSEcCtD
Sevoflurane—Body temperature increased—Dexamethasone—psoriasis	0.000159	0.000456	CcSEcCtD
Sevoflurane—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000159	0.00359	CbGpPWpGaD
Sevoflurane—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000158	0.00359	CbGpPWpGaD
Sevoflurane—Insomnia—Prednisone—psoriasis	0.000158	0.000455	CcSEcCtD
Sevoflurane—Nausea—Cyclosporine—psoriasis	0.000157	0.000451	CcSEcCtD
Sevoflurane—Pruritus—Triamcinolone—psoriasis	0.000157	0.00045	CcSEcCtD
Sevoflurane—Cough—Methotrexate—psoriasis	0.000156	0.000449	CcSEcCtD
Sevoflurane—Dizziness—Hydrocortisone—psoriasis	0.000156	0.000447	CcSEcCtD
Sevoflurane—Convulsion—Methotrexate—psoriasis	0.000155	0.000446	CcSEcCtD
Sevoflurane—Nausea—Mycophenolate mofetil—psoriasis	0.000153	0.00044	CcSEcCtD
Sevoflurane—Chest pain—Methotrexate—psoriasis	0.000153	0.000438	CcSEcCtD
Sevoflurane—Rash—Prednisolone—psoriasis	0.000152	0.000436	CcSEcCtD
Sevoflurane—Dermatitis—Prednisolone—psoriasis	0.000152	0.000436	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000152	0.000435	CcSEcCtD
Sevoflurane—Headache—Prednisolone—psoriasis	0.000151	0.000433	CcSEcCtD
Sevoflurane—Vomiting—Hydrocortisone—psoriasis	0.00015	0.00043	CcSEcCtD
Sevoflurane—ALB—Lipoprotein metabolism—APOE—psoriasis	0.000149	0.00338	CbGpPWpGaD
Sevoflurane—Rash—Hydrocortisone—psoriasis	0.000148	0.000426	CcSEcCtD
Sevoflurane—ND1—Metabolism—CYP2S1—psoriasis	0.000148	0.00336	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CYP2S1—psoriasis	0.000148	0.00336	CbGpPWpGaD
Sevoflurane—Dermatitis—Hydrocortisone—psoriasis	0.000148	0.000426	CcSEcCtD
Sevoflurane—Confusional state—Methotrexate—psoriasis	0.000147	0.000424	CcSEcCtD
Sevoflurane—Headache—Hydrocortisone—psoriasis	0.000147	0.000423	CcSEcCtD
Sevoflurane—Dizziness—Triamcinolone—psoriasis	0.000146	0.000421	CcSEcCtD
Sevoflurane—Anaphylactic shock—Methotrexate—psoriasis	0.000146	0.00042	CcSEcCtD
Sevoflurane—Feeling abnormal—Prednisone—psoriasis	0.000144	0.000414	CcSEcCtD
Sevoflurane—Asthenia—Dexamethasone—psoriasis	0.000144	0.000414	CcSEcCtD
Sevoflurane—Asthenia—Betamethasone—psoriasis	0.000144	0.000414	CcSEcCtD
Sevoflurane—Nervous system disorder—Methotrexate—psoriasis	0.000143	0.000412	CcSEcCtD
Sevoflurane—Thrombocytopenia—Methotrexate—psoriasis	0.000143	0.000411	CcSEcCtD
Sevoflurane—Nausea—Prednisolone—psoriasis	0.000143	0.000411	CcSEcCtD
Sevoflurane—Pruritus—Betamethasone—psoriasis	0.000142	0.000408	CcSEcCtD
Sevoflurane—Pruritus—Dexamethasone—psoriasis	0.000142	0.000408	CcSEcCtD
Sevoflurane—Skin disorder—Methotrexate—psoriasis	0.000142	0.000408	CcSEcCtD
Sevoflurane—Vomiting—Triamcinolone—psoriasis	0.000141	0.000404	CcSEcCtD
Sevoflurane—Nausea—Hydrocortisone—psoriasis	0.00014	0.000401	CcSEcCtD
Sevoflurane—Rash—Triamcinolone—psoriasis	0.00014	0.000401	CcSEcCtD
Sevoflurane—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00014	0.00316	CbGpPWpGaD
Sevoflurane—Dermatitis—Triamcinolone—psoriasis	0.00014	0.000401	CcSEcCtD
Sevoflurane—Urticaria—Prednisone—psoriasis	0.000139	0.000399	CcSEcCtD
Sevoflurane—Headache—Triamcinolone—psoriasis	0.000139	0.000398	CcSEcCtD
Sevoflurane—Body temperature increased—Prednisone—psoriasis	0.000138	0.000397	CcSEcCtD
Sevoflurane—Hypotension—Methotrexate—psoriasis	0.000137	0.000393	CcSEcCtD
Sevoflurane—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000137	0.0031	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL13—psoriasis	0.000135	0.00307	CbGpPWpGaD
Sevoflurane—Dizziness—Dexamethasone—psoriasis	0.000133	0.000382	CcSEcCtD
Sevoflurane—Dizziness—Betamethasone—psoriasis	0.000133	0.000382	CcSEcCtD
Sevoflurane—Insomnia—Methotrexate—psoriasis	0.000132	0.00038	CcSEcCtD
Sevoflurane—Nausea—Triamcinolone—psoriasis	0.000132	0.000378	CcSEcCtD
Sevoflurane—Dyspnoea—Methotrexate—psoriasis	0.00013	0.000374	CcSEcCtD
Sevoflurane—Somnolence—Methotrexate—psoriasis	0.00013	0.000373	CcSEcCtD
Sevoflurane—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000129	0.00293	CbGpPWpGaD
Sevoflurane—Hypersensitivity—Prednisone—psoriasis	0.000129	0.00037	CcSEcCtD
Sevoflurane—Vomiting—Betamethasone—psoriasis	0.000128	0.000367	CcSEcCtD
Sevoflurane—Vomiting—Dexamethasone—psoriasis	0.000128	0.000367	CcSEcCtD
Sevoflurane—Rash—Betamethasone—psoriasis	0.000127	0.000364	CcSEcCtD
Sevoflurane—Rash—Dexamethasone—psoriasis	0.000127	0.000364	CcSEcCtD
Sevoflurane—Dermatitis—Dexamethasone—psoriasis	0.000127	0.000364	CcSEcCtD
Sevoflurane—Dermatitis—Betamethasone—psoriasis	0.000127	0.000364	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Methotrexate—psoriasis	0.000126	0.000363	CcSEcCtD
Sevoflurane—Headache—Betamethasone—psoriasis	0.000126	0.000362	CcSEcCtD
Sevoflurane—Headache—Dexamethasone—psoriasis	0.000126	0.000362	CcSEcCtD
Sevoflurane—Asthenia—Prednisone—psoriasis	0.000126	0.000361	CcSEcCtD
Sevoflurane—Pain—Methotrexate—psoriasis	0.000125	0.000359	CcSEcCtD
Sevoflurane—Pruritus—Prednisone—psoriasis	0.000124	0.000356	CcSEcCtD
Sevoflurane—ALB—Hemostasis—SERPINB8—psoriasis	0.000122	0.00276	CbGpPWpGaD
Sevoflurane—Feeling abnormal—Methotrexate—psoriasis	0.000121	0.000346	CcSEcCtD
Sevoflurane—Nausea—Betamethasone—psoriasis	0.000119	0.000343	CcSEcCtD
Sevoflurane—Nausea—Dexamethasone—psoriasis	0.000119	0.000343	CcSEcCtD
Sevoflurane—Urticaria—Methotrexate—psoriasis	0.000116	0.000334	CcSEcCtD
Sevoflurane—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	0.000116	0.00263	CbGpPWpGaD
Sevoflurane—Dizziness—Prednisone—psoriasis	0.000116	0.000332	CcSEcCtD
Sevoflurane—Body temperature increased—Methotrexate—psoriasis	0.000116	0.000332	CcSEcCtD
Sevoflurane—Vomiting—Prednisone—psoriasis	0.000111	0.00032	CcSEcCtD
Sevoflurane—Rash—Prednisone—psoriasis	0.00011	0.000317	CcSEcCtD
Sevoflurane—Dermatitis—Prednisone—psoriasis	0.00011	0.000317	CcSEcCtD
Sevoflurane—Headache—Prednisone—psoriasis	0.00011	0.000315	CcSEcCtD
Sevoflurane—GRIA1—BDNF signaling pathway—JUN—psoriasis	0.000109	0.00247	CbGpPWpGaD
Sevoflurane—Hypersensitivity—Methotrexate—psoriasis	0.000108	0.000309	CcSEcCtD
Sevoflurane—GRIA1—BDNF signaling pathway—NFKB1—psoriasis	0.000105	0.00238	CbGpPWpGaD
Sevoflurane—Asthenia—Methotrexate—psoriasis	0.000105	0.000301	CcSEcCtD
Sevoflurane—Nausea—Prednisone—psoriasis	0.000104	0.000299	CcSEcCtD
Sevoflurane—Pruritus—Methotrexate—psoriasis	0.000103	0.000297	CcSEcCtD
Sevoflurane—ALB—Folate Metabolism—CAT—psoriasis	0.000102	0.00231	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—CRP—psoriasis	9.96e-05	0.00226	CbGpPWpGaD
Sevoflurane—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	9.9e-05	0.00224	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—APOE—psoriasis	9.75e-05	0.00221	CbGpPWpGaD
Sevoflurane—Dizziness—Methotrexate—psoriasis	9.67e-05	0.000278	CcSEcCtD
Sevoflurane—GRIA1—BDNF signaling pathway—STAT3—psoriasis	9.45e-05	0.00214	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—IL4—psoriasis	9.38e-05	0.00213	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—CP—psoriasis	9.31e-05	0.00211	CbGpPWpGaD
Sevoflurane—Vomiting—Methotrexate—psoriasis	9.3e-05	0.000267	CcSEcCtD
Sevoflurane—Rash—Methotrexate—psoriasis	9.22e-05	0.000265	CcSEcCtD
Sevoflurane—Dermatitis—Methotrexate—psoriasis	9.21e-05	0.000265	CcSEcCtD
Sevoflurane—Headache—Methotrexate—psoriasis	9.16e-05	0.000263	CcSEcCtD
Sevoflurane—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	9.16e-05	0.00208	CbGpPWpGaD
Sevoflurane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.09e-05	0.00206	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—CARM1—psoriasis	8.88e-05	0.00201	CbGpPWpGaD
Sevoflurane—Nausea—Methotrexate—psoriasis	8.69e-05	0.00025	CcSEcCtD
Sevoflurane—CYP3A4—Biological oxidations—CYP2S1—psoriasis	8.53e-05	0.00193	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL10—psoriasis	8.46e-05	0.00192	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	8.41e-05	0.00191	CbGpPWpGaD
Sevoflurane—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	8.29e-05	0.00188	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—CAT—psoriasis	8.11e-05	0.00184	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—CRP—psoriasis	8.1e-05	0.00184	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—NFKBIA—psoriasis	8.06e-05	0.00183	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—CP—psoriasis	7.66e-05	0.00174	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—CP—psoriasis	7.55e-05	0.00171	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—ICAM1—psoriasis	7.45e-05	0.00169	CbGpPWpGaD
Sevoflurane—CYP3A4—Tryptophan metabolism—CAT—psoriasis	7.35e-05	0.00167	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—CARM1—psoriasis	7.31e-05	0.00166	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—CARM1—psoriasis	7.24e-05	0.00164	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CARM1—psoriasis	7.24e-05	0.00164	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—CARM1—psoriasis	7.2e-05	0.00163	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—CP—psoriasis	7.14e-05	0.00162	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—CP—psoriasis	7.05e-05	0.0016	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	6.97e-05	0.00158	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—CARM1—psoriasis	6.81e-05	0.00154	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—CARM1—psoriasis	6.73e-05	0.00152	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—CP—psoriasis	6.45e-05	0.00146	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—CRP—psoriasis	6.44e-05	0.00146	CbGpPWpGaD
Sevoflurane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.34e-05	0.00144	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—CP—psoriasis	6.27e-05	0.00142	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—CP—psoriasis	6.15e-05	0.00139	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—CARM1—psoriasis	6.15e-05	0.00139	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—CP—psoriasis	6.05e-05	0.00137	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—CP—psoriasis	6.01e-05	0.00136	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—CARM1—psoriasis	5.98e-05	0.00135	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	5.92e-05	0.00134	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—CP—psoriasis	5.9e-05	0.00134	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—CARM1—psoriasis	5.87e-05	0.00133	CbGpPWpGaD
Sevoflurane—ALB—SLC-mediated transmembrane transport—CP—psoriasis	5.81e-05	0.00132	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	5.8e-05	0.00131	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—CARM1—psoriasis	5.77e-05	0.00131	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—CARM1—psoriasis	5.73e-05	0.0013	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—IFNG—psoriasis	5.67e-05	0.00128	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—CARM1—psoriasis	5.63e-05	0.00128	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—JUN—psoriasis	5.34e-05	0.00121	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—CP—psoriasis	5.16e-05	0.00117	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—NFKB1—psoriasis	5.14e-05	0.00117	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—CARM1—psoriasis	4.92e-05	0.00112	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—NFKB1—psoriasis	4.72e-05	0.00107	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NDUFA5—psoriasis	4.68e-05	0.00106	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—CXCL8—psoriasis	4.63e-05	0.00105	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—STAT3—psoriasis	4.62e-05	0.00105	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—TNF—psoriasis	4.51e-05	0.00102	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—IFNG—psoriasis	4.5e-05	0.00102	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—CAT—psoriasis	4.45e-05	0.00101	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CAT—psoriasis	4.45e-05	0.00101	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—JUN—psoriasis	4.3e-05	0.000975	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—NFKB1—psoriasis	4.14e-05	0.000938	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP2S1—psoriasis	3.98e-05	0.000901	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NDUFA5—psoriasis	3.77e-05	0.000855	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—VEGFA—psoriasis	3.76e-05	0.000852	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	3.75e-05	0.000849	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NDUFA5—psoriasis	3.7e-05	0.000838	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—VEGFA—psoriasis	3.67e-05	0.000832	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TNF—psoriasis	3.67e-05	0.000832	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—IL6—psoriasis	3.64e-05	0.000825	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—ITGAL—psoriasis	3.53e-05	0.0008	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	3.5e-05	0.000792	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—APOE—psoriasis	3.46e-05	0.000784	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—APOE—psoriasis	3.46e-05	0.000784	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TP53—psoriasis	3.23e-05	0.000733	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—TNF—psoriasis	3.22e-05	0.00073	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP2S1—psoriasis	3.21e-05	0.000727	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NDUFA5—psoriasis	3.18e-05	0.00072	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP2S1—psoriasis	3.14e-05	0.000712	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PPARG—psoriasis	3.01e-05	0.000683	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PPARG—psoriasis	3.01e-05	0.000683	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.96e-05	0.000671	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—IL6—psoriasis	2.96e-05	0.000671	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—CP—psoriasis	2.95e-05	0.000669	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—TNF—psoriasis	2.91e-05	0.000661	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	2.82e-05	0.000638	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP2S1—psoriasis	2.7e-05	0.000612	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL6—psoriasis	2.6e-05	0.000589	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—IL6—psoriasis	2.35e-05	0.000533	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CARM1—psoriasis	1.94e-05	0.00044	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NDUFA5—psoriasis	1.71e-05	0.000389	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.63e-05	0.000369	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CARM1—psoriasis	1.57e-05	0.000355	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CARM1—psoriasis	1.53e-05	0.000348	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP2S1—psoriasis	1.46e-05	0.00033	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—NOS2—psoriasis	1.45e-05	0.000328	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.42e-05	0.000321	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CARM1—psoriasis	1.32e-05	0.000299	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.23e-05	0.000279	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CAT—psoriasis	1.19e-05	0.000271	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CAT—psoriasis	9.64e-06	0.000218	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CAT—psoriasis	9.44e-06	0.000214	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—APOE—psoriasis	9.28e-06	0.00021	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—VEGFA—psoriasis	8.39e-06	0.00019	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CAT—psoriasis	8.11e-06	0.000184	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PPARG—psoriasis	8.08e-06	0.000183	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—APOE—psoriasis	7.49e-06	0.00017	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—APOE—psoriasis	7.33e-06	0.000166	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CARM1—psoriasis	7.12e-06	0.000161	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PPARG—psoriasis	6.52e-06	0.000148	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PPARG—psoriasis	6.39e-06	0.000145	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—psoriasis	6.34e-06	0.000144	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—APOE—psoriasis	6.3e-06	0.000143	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PPARG—psoriasis	5.49e-06	0.000124	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CAT—psoriasis	4.38e-06	9.93e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—APOE—psoriasis	3.4e-06	7.71e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PPARG—psoriasis	2.96e-06	6.72e-05	CbGpPWpGaD
